BR9809712A - Formas de dosagem de sertralina em solução encapsulada de gelatina - Google Patents

Formas de dosagem de sertralina em solução encapsulada de gelatina

Info

Publication number
BR9809712A
BR9809712A BR9809712-1A BR9809712A BR9809712A BR 9809712 A BR9809712 A BR 9809712A BR 9809712 A BR9809712 A BR 9809712A BR 9809712 A BR9809712 A BR 9809712A
Authority
BR
Brazil
Prior art keywords
sertraline
dosage forms
gelatin solution
encapsulated
encapsulated gelatin
Prior art date
Application number
BR9809712-1A
Other languages
English (en)
Inventor
William John Curatolo
Ravi Mysone Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9809712(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9809712A publication Critical patent/BR9809712A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>''FORMAS DE DOSAGEM DE SERTRALINA EM SOLUçãO ENCAPSULADA DE GELATINA''<D>. Formas de dosagem da sertralina encapsuladas em veículos imiscíveis em água, diminuem o T~ max~ e/ou reduzem os efeitos secundários da precipitação da sertralina em meios de utilização contendo o íon cloreto, tais como o trato gastrintestinal.
BR9809712-1A 1997-07-01 1998-06-16 Formas de dosagem de sertralina em solução encapsulada de gelatina BR9809712A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (1)

Publication Number Publication Date
BR9809712A true BR9809712A (pt) 2000-07-11

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809712-1A BR9809712A (pt) 1997-07-01 1998-06-16 Formas de dosagem de sertralina em solução encapsulada de gelatina

Country Status (40)

Country Link
EP (1) EP0980241B1 (pt)
JP (1) JP3585245B2 (pt)
KR (1) KR100371730B1 (pt)
CN (1) CN1261792A (pt)
AP (1) AP945A (pt)
AR (1) AR015916A1 (pt)
AT (1) ATE256457T1 (pt)
AU (1) AU724635B2 (pt)
BG (1) BG103917A (pt)
BR (1) BR9809712A (pt)
CA (1) CA2290973C (pt)
CO (1) CO4940405A1 (pt)
DE (1) DE69820608T2 (pt)
DK (1) DK0980241T3 (pt)
DZ (1) DZ2544A1 (pt)
EA (1) EA001905B1 (pt)
ES (1) ES2210760T3 (pt)
GT (1) GT199800090A (pt)
HR (1) HRP980378B1 (pt)
HU (1) HUP0002250A3 (pt)
ID (1) ID24673A (pt)
IL (1) IL133075A0 (pt)
IS (1) IS5266A (pt)
MA (1) MA24586A1 (pt)
MY (1) MY119728A (pt)
NO (1) NO996492L (pt)
NZ (1) NZ501252A (pt)
OA (1) OA11246A (pt)
PA (1) PA8454001A1 (pt)
PE (1) PE97299A1 (pt)
PL (1) PL337807A1 (pt)
PT (1) PT980241E (pt)
SK (1) SK282914B6 (pt)
TN (1) TNSN98123A1 (pt)
TR (1) TR199903282T2 (pt)
TW (1) TW382597B (pt)
UA (1) UA68350C2 (pt)
UY (1) UY25070A1 (pt)
WO (1) WO1999001113A1 (pt)
ZA (1) ZA985709B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
PL348119A1 (en) * 1998-10-13 2002-05-06 Pfizer Prod Inc Sertraline oral concentrate
EP1671628B1 (en) 1999-09-03 2012-10-03 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
CN1728982A (zh) * 2002-10-31 2006-02-01 阿尔扎公司 可增加疏水性药物生物利用度的药物制剂
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525847T2 (de) * 1994-09-19 2002-09-05 Du Pont Pharm Co Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
ES2192217T3 (es) * 1995-07-17 2003-10-01 Pfizer Sertralina para el tratamiento de pacientes tras un infarto de miocardio.

Also Published As

Publication number Publication date
JP2000512316A (ja) 2000-09-19
EA199900963A1 (ru) 2000-08-28
EA001905B1 (ru) 2001-10-22
BG103917A (bg) 2000-07-31
AU724635B2 (en) 2000-09-28
AR015916A1 (es) 2001-05-30
HUP0002250A2 (hu) 2000-12-28
AP945A (en) 2001-02-28
CO4940405A1 (es) 2000-07-24
HRP980378A2 (en) 1999-04-30
NZ501252A (en) 2004-11-26
DK0980241T3 (da) 2004-04-05
DZ2544A1 (fr) 2003-02-08
ID24673A (id) 2000-07-27
EP0980241A1 (en) 2000-02-23
TW382597B (en) 2000-02-21
ATE256457T1 (de) 2004-01-15
HRP980378B1 (en) 2001-12-31
TNSN98123A1 (fr) 2005-03-15
UA68350C2 (en) 2004-08-16
PA8454001A1 (es) 2000-05-24
CA2290973A1 (en) 1999-01-14
TR199903282T2 (xx) 2000-08-21
SK282914B6 (sk) 2003-01-09
MY119728A (en) 2005-07-29
PL337807A1 (en) 2000-09-11
ES2210760T3 (es) 2004-07-01
ZA985709B (en) 2000-01-10
PT980241E (pt) 2004-03-31
NO996492L (no) 2000-02-29
CA2290973C (en) 2003-06-17
DE69820608D1 (de) 2004-01-29
UY25070A1 (es) 2000-12-29
AP9801279A0 (en) 1998-06-30
WO1999001113A1 (en) 1999-01-14
HUP0002250A3 (en) 2001-01-29
PE97299A1 (es) 1999-10-13
SK180599A3 (en) 2001-01-18
IL133075A0 (en) 2001-03-19
JP3585245B2 (ja) 2004-11-04
NO996492D0 (no) 1999-12-27
OA11246A (en) 2002-11-19
AU7545098A (en) 1999-01-25
EP0980241B1 (en) 2003-12-17
KR20010013588A (ko) 2001-02-26
DE69820608T2 (de) 2004-12-23
MA24586A1 (fr) 1998-12-31
GT199800090A (es) 1999-12-21
KR100371730B1 (ko) 2003-02-07
IS5266A (is) 1999-11-23
CN1261792A (zh) 2000-08-02

Similar Documents

Publication Publication Date Title
FI973419A (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d&#39;acide salicylique
NO990793L (no) 7&lt;alfa&gt;-(&lt;Epsilon&gt;-aminoalkyl)-°stratriener, fremgangsmÕte for fremstilling av disse, farmas°ytiske preparater inneholdende disse, samt deres anvendelse for fremstilling av legemidler
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
DE69905170T2 (de) Thiazolopyrimidinderivate
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
BR9914674A (pt) Grânulo matriz
BR9809712A (pt) Formas de dosagem de sertralina em solução encapsulada de gelatina
EP0853486A4 (en) THERAPEUTIC USE OF ANIMAL SERUMS, ESPECIALLY HORSES, FOR THE TREATMENT OF AIDS, CANCER AND OTHER VIRAL AND BACTERIAL DISEASES
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
DE60229867D1 (de) Zielgerichtete ligande gegen peyer&#39;s flecke- und/oder m-zellen
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
FR2786100B1 (fr) Nouvelle application therapeutique de la nicergoline
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
BR0306869A (pt) Composição farmacêutica orodispersìvel de piribedila

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 36 DA LPI .